Berkeley Lights, Inc. (BLI)
Berkeley Lights, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in EmeryVille, CA, US. The stock last traded at $1.20, down 5.88% on the session, giving a market capitalisation of $86.6M. On trailing twelve-month figures it carries a trailing P/E of -0.85, a net margin of -124.7%. Its beta of 1.36 implies it has historically moved more than the broad market.
Berkeley Lights, Inc. (BLI) is a digital cell biology firm dedicated to empowering and expediting the advancement and market introduction of biotherapeutic and other cell-based products. The company provides a unified technology platform, which encompasses proprietary consumables such as OptoSelect chips and specialized reagent kits, sophisticated automation systems, and purpose-built application and workflow software. BLI extends its services to clients across North America, the Asia Pacific region, and Europe. Founded in 2011, its corporate headquarters are located in Emeryville, California.
Berkeley Lights, Inc. is most often compared with the following Healthcare names: